Table 1.
Baseline characteristics of participants
| Variable | Baseline | T6 | T12 | p-valuea |
|---|---|---|---|---|
| Weight (Kg) | 96.2 (82.6,107.9) | 96.5 (79.5,105.5) | 91.5 (79.6, 103.2) | < 0.001 |
| BMI (kg/m2) | 31.6 (28.6, 38.0) | 31.6 (28.0, 38.0) | 31.1 (27.8, 36.1) | < 0.001 |
| Waist circumference (cm) | 114.0 (101.5, 118.8) | 109.0 (97.0, 116.0) | 109.0 (93.0, 116.0) | 0.264 |
| Hip circumference (cm) | 113.5 (105.2,121.2) | 115.0 (102.0,122.0) | 112.0 (101.5,118.5) | 0.936 |
| WHR | 1.0 (0.9, 1.0) | 1.0 (1.0, 1.1) | 1.0 (0.9, 1.0) | 0.694 |
| Systolic blood pressure (mmHg) | 145.0 (117.5, 150.0) | 132.5 (128.8, 140.0) | 125.0 (120.0, 136.2) | 0.135 |
| Diastolic blood pressure (mmHg) | 80.0 (71.2, 90.0) | 80.0 (73.8, 85.0) | 78.0 (70.0, 81.2) | 0.359 |
| PREDIMED | 7.5 (7.0, 8.0) | 9.0 (9.0, 10.0) | 8.5 (8.0, 9.8) | 0.009 |
| PREDIMED_CLASS, n(%) | 0.761b | |||
| - No adherence | 1 (5.6%) | 0 (0.0%) | 0 (0.0%) | |
| - Adherence | 14 (77.8%) | 10 (58.8%) | 13 (72.2%) | |
| - Max adherence | 3 (16.7%) | 7 (41.2%) | 5 (27.8%) | |
| IPAQ, n(%) | 0.717b | |||
| - low | 9 (50.0%) | 5 (29.4%) | 4 (22.2%) | |
| - moderate | 6 (33.3%) | 8 (47.1%) | 7 (38.9%) | |
| - high | 3 (16.7%) | 4 (23.5%) | 7 (38.9%) | |
| Fasting blood glucose (mg/dl) | 138.0 (115.0, 149.0) | 107.0 (105.0, 108.0) | 110.0 (103.5, 125.0) | 0.106 |
| Hba1c (%) | 6.5 (6.3, 7.4) | 6.2 (6.1, 6.3) | 6.2 (5.4, 6.5) | 0.267 |
| Total cholesterol (mg/dL) | 201.0 (196.0, 222.0) | 208.5 (197.5, 231.8) | 195.5 (164.5, 223.5) | 0.606 |
| HDL (mg/dL) | 40.0 (37.0, 54.0) | 48.5 (41.0, 54.5) | 47.5 (41.8, 52.8) | 0.139 |
| TG (mg/dL) | 139.5 (102.8, 213.8) | 118.5 (94.8, 186.8) | 113.0 (94.8, 145.8) | 0.078 |
| LDL (mg/dL) | 122.4 (104.6, 142.2) | 132.7 (121.9, 155.4) | 124.9 (101.5, 140.2) | 0.952 |
Statistically significant values are given in bold
Data are expressed as median (Q1–Q3). a p-value derived from Friedman Test; b p-value derived from chi-squared test